↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Coull B) "

Search: WFRF:(Coull B)

Result 1-3 of 3

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Clark, WM, et al. (author) Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (vol 16, pg 389, 2003) 2004 In: CEREBROVASCULAR DISEASES. - 1015-9770. ; 17:1, s. 91-92 Journal article (other academic/artistic)
2.	Neal, DE, et al. (author) Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received 2020 In: European urology. - : Elsevier BV. - 1873-7560 .- 0302-2838. ; 77:3, s. 320-330 Journal article (peer-reviewed)
3.	Nassan, Feiby L., et al. (author) Dibutyl-phthalate exposure from mesalamine medications and serum thyroid hormones in men 2019 In: International journal of hygiene and environmental health. - : Urban & Fischer. - 1438-4639 .- 1618-131X. ; 222:1, s. 101-110 Journal article (peer-reviewed)abstract BACKGROUND: Dibutyl phthalate (DBP) is an endocrine disruptor and used in some medication coatings, such as mesalamine for treatment inflammatory bowel disease (IBD).OBJECTIVES: To determine whether high-DBP from some mesalamine medications alters thyroid function.METHODS: Seventy men with IBD, without thyroid disease or any radiation history participated in a crossover-crossback prospective study and provided up to 6 serum samples (2:baseline, 2:crossover, 2:crossback). Men on non-DBP mesalamine (background exposure) at baseline crossed-over to DBP-mesalamine (high exposure) then crossed-back to non-DBP mesalamine (B1HB2-arm) and vice versa for men on DBP-mesalamine at baseline (H1BH2-arm). Serum concentrations of total triiodothyronine (T3), total thyroxine (T4), free triiodothyronine (FT3), free thyroxine (FT4), thyroid-stimulating hormone (TSH) and thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TgAb).RESULTS: After crossover in B1HB2-arm (26 men, 134 samples), T3 decreased 10% (95% confidence interval (CI): 14%,-5%), T3/T4 ratio decreased 8% (CI: 12%,-3%), TPOAb, and TgAb concentrations decreased, 11% (-20%, -2%) and 15% (-23%, -5%), respectively; after crossback, they increased. When men in the H1BH2-arm (44 men, 193 samples) crossed-over, T3 decreased 7% (CI: -11%, -2%) and T3/T4 ratio decreased 6% (CI: -9%, -2%). After crossback, only TgAb increased and FT4 decreased.CONCLUSIONS: High-DBP novel exposure or removal from chronic high-DBP exposure could alter elements of the thyroid system, and most probably alters the peripheral T4 conversion to T3 and thyroid autoimmunity, consistent with thyroid disruption. After exposure removal, these trends were mostly reversed.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-3 of 3

Refine your search

Type of publication: journal article (3)

Type of content: peer-reviewed (2); other academic/artistic (1)

Author/Editor: Smith, D. (2); Hill, E. (1); Hsu, C. (1); Slater, M. (1); Williams, S. (1); Wilson, A. (1); show more...; Harvey, A. (1); Nash, M. (1); Baker, S. (1); Robinson, M. (1); Conway, J. (1); Moore, R. (1); Wilson, P. (1); Martin, A. (1); Scott, R. (1); Kaste, M. (1); Wills, L. (1); Jones, A. (1); Terent, A (1); Grant, A. (1); Gray, C. (1); Williams, L. (1); Dixon, N. (1); Graham, G. (1); Bhattarai, S (1); Chaturvedi, S (1); Freeman, A (1); Schneider, D. (1); Hart, L. (1); Carr, J. (1); Comi, G (1); Marshall, F. (1); Davies, C (1); Baum, M (1); HUGHES, L (1); Wilkinson, J. (1); Smith, L (1); Harris, J. (1); Cooper, D (1); Griffiths, D (1); Rees, M (1); Wagner, A. (1); Graham, J. (1); Chollet, F. (1); Adolfsson, J. (1); Moore, S. (1); Thompson, P. (1); Toole, J. (1); Paul, A (1); Harris, B (1); show less...

University: Karolinska Institutet (2); Örebro University (1)

Language: English (3)

Research subject (UKÄ/SCB): Medical and Health Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view